Semax

$40.00

8 in stock

SKU: SX10 Category:

Description

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, VETERINARY USE, OR IN VIVO DIAGNOSTIC PURPOSES.

Product Overview: Semax

Semax is a synthetic heptapeptide analog derived from a fragment of adrenocorticotropic hormone (specifically ACTH 4–10) fused with a C-terminal Pro-Gly-Pro tripeptide motif for enhanced metabolic stability and enzymatic resistance. Engineered primarily for neuroprotective and nootropic applications, Semax stimulates the expression and secretion of Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) in brain tissue without activating peripheral corticosteroid receptors, serving as a primary compound for investigating neuroplasticity, ischemic stroke recovery, and central nervous system modulation.

Primary Purpose: Research settings utilize Semax primarily to investigate neuroprotection, neurogenesis, and cognitive mechanics—specifically by upregulating BDNF and NGF production to enhance synaptic plasticity and protect neuronal populations from ischemic and oxidative damage.

Primary Research Applications & Reasons for Study

  • Neurotrophic Factor Upregulation: Stimulating rapid expression of BDNF and NGF in the hippocampus and basal forebrain to foster neurogenesis and dendritic arborization.
  • Ischemic Hypoxia & Stroke Models: Evaluating survival rates of cortical neurons and microvascular protection under acute hypoxic or hypoperfusion stress.
  • Dopaminergic & Cholinergic Modulation: Studying the regulation of central dopamine and serotonin turnover, as well as high-affinity choline transport, to assess cognitive processing and focus parameters.
  • Optic Nerve & Ocular Protection: Investigating neuroretinal preservation and ganglion cell survival in degenerative optic nerve injury models.

Expected Research Results & Timeline Metrics

  • Phase 1 / Hours 1–24
    Rapid Gene Expression Shift: Immediate surge in hippocampal BDNF mRNA expression and elevated dopamine synthesis within hours of exposure.
  • Phase 2 / Weeks 1–2
    Synaptic Density & Cytoprotection: Statistically significant reductions in neuronal apoptosis under oxidative conditions and increased synaptic density across memory network models.
  • Phase 3 / Weeks 3–6
    Sustained Neurofunctional Recovery: Marked recovery of cognitive performance markers in lesion models and stabilized microvascular blood flow parameters in chronic central nervous system assays.

Key Research Benefits

  • Potent Neurotrophic Stimulator: Dramatically boosts endogenous BDNF and NGF levels without exogenous growth factor administration.
  • Non-Hormonal ACTH Fragment: Delivers neuroprotective properties without triggering systemic adrenal steroidogenesis or cortisol secretion.
  • Enzymatic Resistance: C-terminal Pro-Gly-Pro tripeptide protection extends half-life and biological activity in peptide cleavage assays.
  • Dual Nootropic & Ischemic Standard: Highly versatile candidate for studying learning kinetics, memory retention, and vascular brain injury models.

Regulatory Compliance & Legal Research Disclaimer

THIS PRODUCT IS INTENDED SOLELY FOR IN VITRO LABORATORY RESEARCH AND EXPERIMENTAL PURPOSES. It is strictly prohibited for human consumption, clinical trials, therapeutic administration, cosmetic use, or veterinary application. This product is not an FDA-approved drug, medical food, or dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease, illness, or medical condition. Any handling, reconstitution, or experimentation involving this chemical compound must be conducted strictly by qualified, trained laboratory professionals utilizing appropriate containment and personal protective equipment in accordance with scientific biosafety standards. Buyers and users assume full liability for compliance with local, state, and federal laws regarding the handling and possession of research compounds.

Additional information

Size

10 mg

Add to cart